Artificial intelligence is no longer just spotting tumors a little faster than humans. In study after study, machine learning systems are uncovering hidden patterns in cancer data that even veteran ...

As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

OncoInv has signed a distribution partnership with MaxBloch Clinical Laboratories to introduce the OncoSeek® multi-cancer ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: ...

Detailed price information for Biomark Diagnostics Inc (BMKDF) from The Globe and Mail including charting and trades.

Conventional diagnostic tools, such as ultrasound, MRI, PET, CT scans, and scintigraphy, often identify cancer only at later stages. These methods can be expensive, expose patients to radiation, and ...